AKT ligands and polynucleotides encoding AKT ligands
US8263357B2 · kind B2 · utility
14Cited by
2References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 2, 2011 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Mar 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/60
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate AKT activity. The ligands, homopolyligands, and heteropolyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands, homopolyligands, and heteropolyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands, homopolyligands, and heteropolyligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.